NEW YORK (GenomeWeb) – Roche announced today that the US Food and Drug Administration has approved the use of Roche's Cobas Zika assay to screen blood samples under an Investigational New Drug application protocol.

The Cobas Zika test is a qualitative in vitro nucleic acid screening test for the direct detection of Zika virus in plasma specimens from individual human blood donors. It is designed for use with Roche's fully automated Cobas 6800/8800 Systems, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

Nov
07
Sponsored by
Qiagen

This webinar will provide a first-hand look at how a leading pathology lab implemented a next-generation sequencing panel to capture comprehensive molecular tumor profiles.

Nov
29
Sponsored by
Schott

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.